LCTX:NYSEAMERICAN
Lineage Cell Therapeutics Inc
0,94Â US$
arrow_upward
+1,13%(+0,011) 1K
0,95Â US$
arrow_upward
+1,70% (+0,016)bedtimeYopilgandan keyin
Savdolar yopilgan: 6-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoLCTX tikeri uchun statistika yaratilmoqda...
Ochish
0,94Â US$
Yuqori
0,96Â US$
Past
0,92Â US$
Bozor kapitali
237,28Â mln
Oʻrtacha hajm
1,34Â mln
Hajmi
967,62Â ming
52 haftalik eng yuqori
2,09Â US$
52 haftalik eng past
0,88Â US$
Aksiya boʻyicha daromad
-0,14Â US$
Beta
1,60
Muomaladagi aksiyalar
252,91Â mln
Xodimlar soni
75
Ochish
0,94Â US$
Yuqori
0,96Â US$
Past
0,92Â US$
Bozor kapitali
237,28Â mln
Oʻrtacha hajm
1,34Â mln
Hajmi
967,62Â ming
52 haftalik eng yuqori
2,09Â US$
52 haftalik eng past
0,88Â US$
Aksiya boʻyicha daromad
-0,14Â US$
Beta
1,60
Muomaladagi aksiyalar
252,91Â mln
Xodimlar soni
75
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Moomoo
·
32 daqiqa oldin
S&P 500 Surpasses 7,840 Points: Why Is BTC Absent?
富途牛牛
·
6 daqiqa oldin
10-year U.S. Treasury yields surge to 5.3%, while the Nasdaq and S&P 500 hit new highs—how should we interpret this unusual equity-bond dynamic?
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Lineage Cell Therapeutics Inc haqida